Nicotine Lozenge
Product Images NDC 0363-7044

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Nicotine (NDC 0363-7044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Walgreen Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

74m-94-nicotine-lozenge (74m 94 Nicotine Lozenge)

Walgreens Nicotine Lozenge 4 mg (nicotine polacrilex) oral lozenge packaging label. The box contains 80 coated lozenges and is labeled as a stop smoking aid with a mint flavor. The label includes dosage instructions, drug facts, warnings, and inactive ingredients. The product is distributed by Walgreen Co, Deerfield, IL.*

FDA Label Image

Wallet Card 1-image (Image 01)

A text panel titled 'WHERE TO CALL FOR HELP' listing phone numbers for support organizations: American Lung Association (1-800-586-4872), American Cancer Society (1-800-227-2345), and American Heart Association (1-800-242-8721). It also suggests contacting a 'Quitting Buddy or Friend who has Quit.' This panel provides resources for quitting smoking support.*

FDA Label Image

Wallet Card 2-image (Image 02)

An illustration featuring a blue dashed border with the heading 'My most important reasons to quit smoking are:' in blue text. Below the heading are five blank horizontal lines for writing reasons, intended to support smoking cessation.*

FDA Label Image

Smoke Free Habits-image (Image 03)

FDA Label Image

Upc-image (Image 04)

FDA Label Image

Reminder Sticker-image (Image 05)

An instructional diagram for nicotine polacrilex lozenge dosing schedule. It shows Step 1 at quit date: 1 lozenge every 1 to 2 hours, Step 2 at week 7: 1 lozenge every 2 to 4 hours, Step 3 at week 10: 1 lozenge every 4 to 8 hours, and the Ex-Smoker stage at 12 weeks after quit date with no lozenge use indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.